STAT3 and cancer: Considering that the IL-6R/JAK/STAT3 pathway is aberrantly hyperactivated in >70% of cancers, it would be interesting to determine if impairing the palmitoylation of STAT3 with the use of phytochemicals would prove to be successful in hampering cancer cell growth [38].